234 related articles for article (PubMed ID: 36799979)
1. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
2. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
3. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
4. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
[TBL] [Abstract][Full Text] [Related]
5. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
6. A new methodology to reveal potential nucleic acid modifications associated with the risk of endometrial cancer through dispersive solid-phase extraction coupled with UHPLC-QE-Orbitrap-MS/MS and HPLC-UV.
Zhao H; Zhang X; Zuo L; Li L; Yang H; Zhang M; Wang N; Jia Q; Liu Y
Anal Bioanal Chem; 2024 Apr; 416(10):2439-2452. PubMed ID: 38400939
[TBL] [Abstract][Full Text] [Related]
7. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
[TBL] [Abstract][Full Text] [Related]
8. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
9. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
PeerJ; 2023; 11():e16424. PubMed ID: 38077439
[TBL] [Abstract][Full Text] [Related]
10. The plasma lipidome of the Quaker parrot (Myiopsitta monachus).
Beaufrère H; Gardhouse SM; Wood RD; Stark KD
PLoS One; 2020; 15(12):e0240449. PubMed ID: 33259543
[TBL] [Abstract][Full Text] [Related]
11. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
12. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
[TBL] [Abstract][Full Text] [Related]
13. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract][Full Text] [Related]
14. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
Chen J; Liu J; Cao D
BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
[TBL] [Abstract][Full Text] [Related]
15. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
16. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature.
Ecker J; Benedetti E; Kindt ASD; Höring M; Perl M; Machmüller AC; Sichler A; Plagge J; Wang Y; Zeissig S; Shevchenko A; Burkhardt R; Krumsiek J; Liebisch G; Janssen KP
Gastroenterology; 2021 Sep; 161(3):910-923.e19. PubMed ID: 34000281
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential serum markers for endometrial cancer using protein expression profiling.
Takano M; Kikuchi Y; Asakawa T; Goto T; Kita T; Kudoh K; Kigawa J; Sakuragi N; Sakamoto M; Sugiyama T; Yaegashi N; Tsuda H; Seto H; Shiwa M
J Cancer Res Clin Oncol; 2010 Mar; 136(3):475-81. PubMed ID: 19756734
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
[TBL] [Abstract][Full Text] [Related]
20. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]